ArticleSurgical neurology international2025
Magnetic resonance-guided stereotactic biopsy in intracranial lesions.
Article in Surgical neurology international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Findings and statistical data showed that stereotactic biopsy has an effective role in histopathological diagnosis of brain tumors and lesions and accordingly in creating a treatment protocol. Methods: In our clinic, 143 biopsy procedures were performed on 142 patients between 2014 and 2022. Consistency rates were evaluated by comparing preoperative diagnoses with postoperative diagnoses. Results: Postoperative complications occurred in 7 patients. Complications were observed in 2 patients due to surgery. 4 patients died, not related to our surgical procedures. In 8.4% of the patients, a pathological diagnosis was not performed. The correct diagnosis rate is 91.6% in our group. In this study, a magnetic resonance-compatible Leksell frame was used. Conclusion: Because of its high diagnostic value and low morbidity and mortality rates, stereotactic biopsy is a reliable and indisputable neurosurgical technique which is used worldwide.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.